Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6875785B2 · kind B2 · utility
0Cited by
44References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2002 |
| Grant date | Apr 5, 2005 |
| Priority date | — |
| Expiry date | Sep 25, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D263/32
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating disorders mediated by cyclooxygenase-2 or 5-lipoxygenase, such as inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.